Biocon Q2 PAT seen up 2.6% to Rs 171 cr: Centrum

Net Sales are expected to increase by 3.5 percent Q-o-Q (up 21.5 percent Y-o-Y) to Rs 1017 crore, according to Centrum.
  • Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead GrowMyMoney IThe Winning Leap SME Special
Moneycontrol

Home » News » Earnings » Brokerage Results Estimates

Oct 19, 2016, 03.08 PM | Source: Moneycontrol.com

Biocon Q2 PAT seen up 2.6% to Rs 171 cr: Centrum

Net Sales are expected to increase by 3.5 percent Q-o-Q (up 21.5 percent Y-o-Y) to Rs 1017 crore, according to Centrum.

Like this story, share it with millions of investors on M3

Biocon Q2 PAT seen up 2.6% to Rs 171 cr: Centrum

Net Sales are expected to increase by 3.5 percent Q-o-Q (up 21.5 percent Y-o-Y) to Rs 1017 crore, according to Centrum.

Post Your Comments

Share Cancel

Centrum Broking (more)

, Centrum Broking |

Centrum has come out with its second quarter (July-September) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Biocon to report net profit at Rs 171 crore, up 2.6 percent quarter-on-quarter.

Net Sales are expected to increase by 3.5 percent Q-o-Q (up 21.5 percent Y-o-Y) to Rs 1017 crore, according to Centrum.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 1.1 percent Q-o-Q (up 34.6 percent Y-o-Y) to Rs 266 crore.

Centrum's report on Biocon

Biocon’s net profit is likely to grow by 15% YoY and by 3% QoQ to Rs1.71bn. We expect the company to perform better in future due to the recent approval of insulin glargine in Japan and commencement of insulin manufacturing facility in Malaysia.

The company’s EBIDTA margin is expected to grow by 260bps YoY to 26.2% from 23.6% due to the overall decline in expenses. Biocon’s material cost is likely to decline by 10bps to 39.3% from 39.4%.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

To read the full report click here

Tags  Biocon Centrum
Buy, Hold, Sell ? Hear it first on M3
Biocon Q2 PAT seen up 2.6% to Rs 171 cr: Centrum

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login